GSK plc announced the repurchase of 15,858 ordinary shares on September 18, 2025, at prices ranging from 1,471.00p to 1,480.00p each, part of a larger buyback program totaling 29,330,461 shares purchased since June 4, 2025. The company now holds 247,464,844 shares in treasury out of 4,067,938,124 shares issued.